| 000 | 01785 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513190418.0 | ||
| 264 | 0 | _c19990902 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.274.32.22313 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAdak, S | |
| 245 | 0 | 0 |
_aRole of reductase domain cluster 1 acidic residues in neuronal nitric-oxide synthase. Characterization of the FMN-FREE enzyme. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cAug 1999 |
||
| 300 |
_a22313-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a2,6-Dichloroindophenol _xmetabolism |
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aAmino Acids, Dicarboxylic _xgenetics |
| 650 | 0 | 4 |
_aAspartic Acid _xgenetics |
| 650 | 0 | 4 |
_aCalmodulin _xpharmacology |
| 650 | 0 | 4 | _aConserved Sequence |
| 650 | 0 | 4 |
_aCytochrome c Group _xmetabolism |
| 650 | 0 | 4 | _aElectron Transport |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aFerricyanides _xmetabolism |
| 650 | 0 | 4 |
_aFlavin Mononucleotide _xmetabolism |
| 650 | 0 | 4 |
_aFlavoproteins _xdrug effects |
| 650 | 0 | 4 | _aFluorescence |
| 650 | 0 | 4 |
_aGlutamic Acid _xgenetics |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xdrug effects |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type I |
| 650 | 0 | 4 | _aSequence Homology, Amino Acid |
| 700 | 1 | _aGhosh, S | |
| 700 | 1 | _aAbu-Soud, H M | |
| 700 | 1 | _aStuehr, D J | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 274 _gno. 32 _gp. 22313-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.274.32.22313 _zAvailable from publisher's website |
| 999 |
_c10386728 _d10386728 |
||